📰 Ipca Laboratories News
Page 17 - Ipca Laboratories News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ipca Laboratories. Real-time updates on events, politics, business and more.
June 26, 2023
As many as 88 stocks were on the short-covering list based on the open interest percentage. These included Rain Industries, Hindustan Aeronautics, Dr Lal PathLabs, LIC Housing Finance and Mahanagar Gas
June 25, 2023
Based on the OI percentage, a short build-up was seen in 90 stocks including Dr Lal PathLabs, Hindustan Aeronautics, Ramco Cements, MCX India, and Mahanagar Gas.
June 22, 2023
The Nifty Pharma index was trading 0.14 per cent down at 13229.2.
June 21, 2023
The Nifty Pharma index closed 0.07 per cent up at 13247.7.
June 20, 2023
The Nifty Pharma index was trading 0.29 per cent down at 13226.3.
June 20, 2023
The Nifty Pharma index closed 0.19 per cent down at 13238.85.
June 18, 2023
Based on the OI percentage, 87 stocks including Oracle Financial, Dr Lal PathLabs, LTIMindtree, Metropolis Healthcare, and Ashok Leyland saw a long build-up.
June 15, 2023
Based on the OI percentage, 63 stocks including Tata Chemicals, Dr Lal PathLabs, Wipro, Federal Bank and State Bank of India saw a short build-up.
June 14, 2023
Shares of Indian pharmaceutical company, Ipca Laboratories, fell by 3% after the US Food and Drug Administration (USFDA) issued a Form 483 report, citing 11 observations of its API manufacturing facility situated in Ratlam. Form 483 is issued when an inspector has found conditions that could violate FDA regulations. Ipca said it takes quality and compliance issues seriously and will submit a response in the prescribed time. Trendlyne data showed that the stocks day RSI (14) is at 57.8, while the...
June 14, 2023
The US FDA issued a Form 483 with 11 observations to Ipca Laboratories Ltd after conclusion of inspection at API manufacturing facility situated at Ratlam, Madhya Pradesh.